AKT1 and glioblastoma: We have revealed that knocking down SAMD9 expression levels in glioma cells decreased the glioblastoma cell progression via the AKT/PI3K pathway, but the detailed mechanism of how SAMD9 affected the occurrence of gliomas and its impact on tumor immunity has not been reported in gliomas (29).